Evidence map›Paper›PMID 33383876›Full record

ArticleJournal of personalized medicine2020

Evaluation of Male Fertility-Associated Loci in a European Population of Patients with Severe Spermatogenic Impairment.

Miriam Cerván-Martín, Lara Bossini-Castillo, Rocío Rivera-Egea, Nicolás Garrido, Saturnino Luján, Gema Romeu, Samuel Santos-Ribeiro, Ivirma Group, Lisbon Clinical Group, José A Castilla and 24 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Contribution ofFrontiers in cell and developmental biology · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 9 institutions in 3 countries.

Miriam Cerván-MartínDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Lara Bossini-CastilloDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Rocío Rivera-EgeaAndrology Laboratory and Sperm Bank, IVIRMA Valencia, 46015 Valencia, Spain.
Nicolás GarridoIVI Foundation, Health Research Institute La Fe, 46026 Valencia, Spain.
Saturnino LujánServicio de Urología, Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0000-0002-5005-3325
Gema RomeuServicio de Urología, Hospital Universitari i Politecnic La Fe e Instituto de Investigación Sanitaria La Fe (IIS La Fe), 46026 Valencia, Spain.ORCID 0000-0001-6365-1087
Samuel Santos-RibeiroIVI-RMA Lisbon, 1800-282 Lisbon, Portugal.
Ivirma Group
Lisbon Clinical Group
José A CastillaInstituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
M Carmen GonzalvoInstituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
Ana ClaveroInstituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
F Javier VicenteInstituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.
Andrea Guzmán-JiménezDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Cláudia CostaInstituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), 4200-135 Porto, Portugal.
Inés Llinares-BurguetDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Chiranan KhanthamDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Miguel BurgosDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Francisco J BarrionuevoDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Rafael JiménezDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.
Josvany Sánchez-CurbeloLaboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, 08025 Barcelona, Spain.ORCID 0000-0002-6489-3309
Olga López-RodrigoLaboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, 08025 Barcelona, Spain.
M Fernanda PerazaLaboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, 08025 Barcelona, Spain.
Iris Pereira-CaetanoDepartamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.
Patricia I MarquesInstituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), 4200-135 Porto, Portugal.
Filipa CarvalhoInstituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), 4200-135 Porto, Portugal.
Alberto BarrosInstituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), 4200-135 Porto, Portugal.
Lluís BassasLaboratory of Seminology and Embryology, Andrology Service-Fundació Puigvert, 08025 Barcelona, Spain.
Susana SeixasInstituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), 4200-135 Porto, Portugal.ORCID 0000-0002-7035-7422
João GonçalvesDepartamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal.ORCID 0000-0001-9359-8774
Sara LarribaHuman Molecular Genetics Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0003-4579-5452
Alexandra M LopesInstituto de Investigação e Inovação em Saúde, Universidade do Porto (I3S), 4200-135 Porto, Portugal.
Rogelio J Palomino-MoralesInstituto de Investigación Biosanitaria ibs.GRANADA, 18012 Granada, Spain.ORCID 0000-0003-3507-343X
F David CarmonaDepartamento de Genética e Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain.ORCID 0000-0002-1427-7639
Universidad de Granada · ESUniversidade do Porto · PTInstituto de Investigación Biosanitaria de Granada · ESHospital Universitari i Politècnic La Fe · ESPuigvert Foundation · ESInstitut d'Investigació Biomédica de Bellvitge · ESNational Institute of Health Dr. Ricardo Jorge · PTUniversity of Lisbon · PTValencian Infertility Institute · ES

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España IJC2018-038026-IMinisterio de Economía, Industria y Competitividad, Gobierno de España RYC-2014-16458Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2016-78722-R
6 · The paper itself

Abstract

Infertility is a growing concern in developed societies. Two extreme phenotypes of male infertility are non-obstructive azoospermia (NOA) and severe oligospermia (SO), which are characterized by severe spermatogenic failure (SpF). We designed a genetic association study comprising 725 Iberian infertile men as a consequence of SpF and 1058 unaffected controls to evaluate whether five single-nucleotide polymorphisms (SNPs), previously associated with reduced fertility in Hutterites, are also involved in the genetic susceptibility to idiopathic SpF and specific clinical entities. A significant difference in the allele frequencies of

Indexed as

genetic association analysisimpaired spermatogenesisinfertilitynon-obstructive azoospermiasevere oligospermiaSNPs

Identifiers

PMID33383876
PMCPMC7823507
OpenAlexW3116763011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.